Technology Archives - Page 12 of 25 - Boston Life Sciences Times

Caldera Therapeutics Names Michelle Doig CFO and Lee Giguere Chief Legal Officer Ahead of Planned Public Listing

November 2, 2026

Stoke Therapeutics Reports $73.6 Million Third-Quarter Loss, Advances Dravet Syndrome Drug Toward FDA Submission

October 30, 2026

Boston-Based Strand Therapeutics Begins Human Trials of Experimental mRNA Cancer Therapy

October 28, 2026

THIS WEEK'S STORIES

AstraZeneca Reports 7% Third-Quarter Revenue Growth to $16.2 Billion, Reaffirms 2026 Outlook

October 30, 2026

athenahealth Launches AI Integration Allowing Patients to Access Medical Records Through Anthropic’s Claude

November 2, 2026

Pretzel Therapeutics Secures UK Approval to Advance Experimental Mitochondrial Disease Drug Into Phase 2 Trial

October 30, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Technology

GE HealthCare Unveils AI-Powered Allia Celeo Imaging System for Cardiovascular and Interventional Procedures

SCIEX Launches New Software to Accelerate Drug Discovery and Compound Analysis

athenahealth Launches AI Integration Allowing Patients to Access Medical Records Through Anthropic’s Claude

Cambridge-Based Elemental Machines Launches AI Tool to Predict Laboratory Equipment Failures Months in Advance

Cambridge-Based Bild Health Launches App to Help GLP-1 Users Preserve Muscle During Weight Loss

Most Read

More Than 4,000 Brigham and Women’s Hospital Nurses Plan Open-Ended Strike Beginning November 12

Baystate Health Integrates Mercy Hospital and 45 Medical Practices, Launches New Electronic Health Record System

Karyopharm Therapeutics Files for Chapter 11 Bankruptcy, Announces Planned Merger with Ayrmid

HSS Medical Supply Signs Distribution Agreement with Abbott for Rapid Molecular Diagnostic Testing Platform

EDITOR PICKS

Caldera Therapeutics Names Michelle Doig CFO and Lee Giguere Chief Legal Officer Ahead of Planned Public Listing

Stoke Therapeutics Reports $73.6 Million Third-Quarter Loss, Advances Dravet Syndrome Drug Toward FDA Submission

Boston-Based Strand Therapeutics Begins Human Trials of Experimental mRNA Cancer Therapy

THIS WEEK'S STORIES

AstraZeneca Reports 7% Third-Quarter Revenue Growth to $16.2 Billion, Reaffirms 2026 Outlook

athenahealth Launches AI Integration Allowing Patients to Access Medical Records Through Anthropic’s Claude

Pretzel Therapeutics Secures UK Approval to Advance Experimental Mitochondrial Disease Drug Into Phase 2 Trial

POPULAR CATEGORY

ABOUT US

FOLLOW US